Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the ...

19:50 EDT Universe Pharmaceuticals (UPC) Inc trading halted, news pending Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses.

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

Pharmaceutical Refrigerator MED-125 from Kirsch Pharmaceutical Refrigerator MED-85 from Kirsch High Credibility: This website adheres to all nine standards of credibility and transparency.

2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception. The industry is grappling with significant market shifts amidst emerging ...

Healthcare & Pharmaceuticalscategory· March 21, 2025 Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on ...

IPC Indice de Precios Y Cotizaciones 52,937.61 265.19 0.50% ...

After hours: March 26 at 7:34:24 PM EDT Loading Chart for VRTX ...

After hours: March 26 at 7:59:26 PM EDT Loading Chart for RCKT ...

Biopharmaceutical company developing drugs for neurological disorders.

Researching and developing therapeutic products for human use.